Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05462834

Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Sleep disordered breathing is associated with impaired glucose tolerance and incident diabetes. Nocturnal hypoxemia is a potential stimulus of glucose intolerance. It is especially severe and highly prevalent in high altitude residents. Intervening on nocturnal hypoxemia may therefore improve glucose control and decrease the public health burden in high altitude populations. The objective of this study is to examine the impact of hypoxemia on glucose homeostasis in high altitude residents. The investigators will address this objective by examining the effect of supplemental oxygen on glucose in a randomized cross-over study.

Conditions

Interventions

TypeNameDescription
OTHERCompressed AirParticipants will be instructed to use compressed air during sleep as a placebo control.
OTHERSupplemental OxygenParticipants will be instructed to use supplemental oxygen at rate of 2lpm during sleep.

Timeline

Start date
2025-12-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2022-07-18
Last updated
2026-01-07

Source: ClinicalTrials.gov record NCT05462834. Inclusion in this directory is not an endorsement.